ROLE OF GLP-1 RECEPTOR AGONISTS IN THE TREATMENT CONTINUUM OF TYPE 2 DIABETES

Volume 1, Issue 8.

Rajesh Garg, MD, Assistant Professor of Medicine, covers the important topic of the role of GLP-1 Receptor Agonists in the Treatment Continuum of Type 2 Diabetes in the format of case-study scenarios for the clinical practice.

Leave a Reply

Your email address will not be published. Required fields are marked *